Epidemiology of primary bone tumors and economical aspects of bone metastases

Bone Cancer

Volumn , Issue , 2010, Pages

  Hauben, Esther I ^a   Hogendoorn, Pancras C W ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882900055     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374895-9.00001-3     Document Type: Chapter

References (42)

1. Dorfman H.D., Czerniak B., Kotz R., Vanel D., Park Y.K., Unni K.K. WHO classification of tumors of bone: introduction. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Soft Tissue and Bone 2002, 226-232. IARC Press, Lyon. C.D.M. Fletcher, K.K. Unni, F. Mertens (Eds.).
2. Van Den Berg H., Slaar A., Kroon H.M., Taminiau A.H., Hogendoorn P. Results of diagnostic review in pediatric bone tumors and tumorlike lesions. J Pediatr Orthop 2008, 28(5):561-564.
3. Hauben E.I., Arends J., Vandenbroucke J.P., van Asperen C.J., Van Marck E., Hogendoorn P.C. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet 2003, 11(8):611-618.
4. Hameetman L., Bovée J.V.M.G., Taminiau A.H.M., Kroon H.M., Hogendoorn P.C.W. Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management. Hereditary Cancer in Clinical Practice 2004, 2(4):161-173.
5. Mertens F., Unni K.K. Enchondromatosis: Ollier disease and Maffucci syndrome. World Health Organization Classification of Tumors. Pathology and genetics of tumors of soft tissue and bone 2002, 356-357. IARC Press, Lyon. C.D.M. Fletcher, K.K. Unni, F. Mertens (Eds.).
6. Schwartz H.S., Zimmerman N.B., Simon M.A., Wroble R.R., Millar E.A., Bonfiglio M. The malignant potential of enchondromatosis. J Bone Joint Surg Am 1987, 69(2):269-274.
7. Unni K.K., Dahlin D.C. Premalignant tumors and conditions of bone. Am J Surg Pathol 1979, 3(1):47-60.
8. Amin R., Ling R. Malignant fibrous histiocytoma following radiation therapy of fibrous dysplasia. Br J Radiol 1995, 68:1119-1122.
9. Taconis W.K. Osteosarcoma in fibrous dysplasia. Skeletal Radiol 1988, 17:163-170.
10. Mulder J.D., Schütte H.E., Kroon H.M., Taconis W.K. Radiologic Atlas of Bone Tumors 1993, Elsevier, Amsterdam. 2nd ed.
11. Huvos A.G. Bone Tumors. Diagnosis, Treatment, and Prognosis 1991, W.B. Saunders Company, Philadelphia. 2nd ed.
12. Dahlin's Bone Tumors General Aspects and Data on 11,087 Cases. 5th ed. Philadelphia: Lippincott-Raven Publishers, 1996.
13. Van Den Berg H., Kroon H.M., Slaar A., Hogendoorn P. Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration 'PALGA'. J Pediatr Orthop 2008, 28(1):29-35.
14. Bovee J.V.M.G., Cleton-Jansen A.M., Taminiau A.H.M., Hogendoorn P.C.W. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncology 2005, 6(8):599-607.
15. Ushigome S., Machinami R., Sorensen P.H. Ewing sarcoma/primitive neuroectodermal tumor (PNET). World Health Organization Classification of Tumors; Pathology & Genetics; Tumors of Soft Tissue and Bone 2002, 298-300. IARC Press, Lyon. C.D.M. Fletcher, K.K. Unni, F. Mertens (Eds.).
16. Guo W., Xu W., Huvos A.G., Healey J.H., Feng C. Comparative frequency of bone sarcomas among different racial groups. Chin Med J (Engl) 1999, 112(12):1101-1104.
17. Oudenhoven L.F., Dhondt E., Kahn S., Nieborg A., Kroon H.M., Hogendoorn P.C., et al. Accuracy of radiography in grading and tissue-specific diagnosis-a study of 200 consecutive bone tumors of the hand. Skeletal Radiol 2006, 35(2):78-87.
18. Van Zwieten K.J., Brys P., Van Rietvelde F., Oudenhoven L., Vanhoenacker F., Willemssens F., et al. Imaging of the hand, techniques and pathology: a pictorial essay. JBR-BTR 2007, 90(5):395-455.
19. Hadjipavlou A., Lander P., Srolovitz H., Enker I.P. Malignant transformation in Paget disease of bone. Cancer 1992, 70:2802-2808.
20. Huvos A.G., Butler A., Bretsky S. Osteogenic sarcoma associated with Paget's disease of bone. A clinicopathologic study of 65 patients. Cancer 1983, 52:1489-1495.
21. Giunti A., Laus M. Malignant tumors in chronic osteomyelitis. (A report of thirty nine cases, twenty six with long term follow up). Ital J Orthop Traumatol 1978, 4(2):171-182.
22. Rubino C., Shamsaldin A., Le M.G., Labbe M., Guinebretiere J.M., Chavaudra J., et al. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat 2005, 89(3):277-288.
23. Huvos A.G., Woodard H.Q. Postradiation sarcomas of bone. Health Phys 1988, 55(4):631-636.
24. Kirova Y.M., RafiH., Voisin M.C., Rieux C., Kuentz M., Mouel S.L., et al. Radiation-induced bone sarcoma following total body irradiation: role of additional radiation on localized areas. Bone Marrow Transplant 2000, 25(9):1011-1013.
25. Domson G.F., Shahlaee A., Reith J.D., Bush C.H., Gibbs C.P. Infarct-associated bone sarcomas. Clin Orthop Relat Res 2009, 20.
26. Gillespie W.J., Frampton C.M., Henderson R.J., Ryan P.M. The incidence of cancer following total hip replacement. J Bone Joint Surg Br 1988, 70(4):539-542.
27. Berrettoni B.A., Carter J.R. Mechanisms of cancer metastasis to bone. J Bone Joint Surg Am 1986, 68(2):308-312.
28. Xu D.L., Zhang X.T., Wang G.H., Li F.B., Hu J.Y. Clinical features of pathologically confirmed metastatic bone tumors-a report of 390 cases. Ai Zheng 2005, 24(11):1404-1407.
29. Desai S., Jambhekar N. Clinicopathological evaluation of metastatic carcinomas of bone: a retrospective analysis of 114 cases over 10 years. Indian J Pathol Microbiol 1995, 38(1):49-54.
30. Coleman R.E. Skeletal complications of malignancy. Cancer 1997, 80(8 Suppl):1588-1594.
31. Rosen L.S., Gordon D., Tchekmedyian S., Yanagihara R., Hirsh V., Krzakowski M., et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003, 21(16):3150-3157.
32. Brown M.L., Lipscomb J., Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 2001, 22:91-113.
33. Cost Analysis: Cost of illness, CDC Econ Eval Tutorials (E),. http://www.cdc.gov/owcd. EET/cost/fixed/3.html.
34. Groot M.T., Boeken Kruger C.G., Pelger R.C., Uyl-de Groot C.A. Costs of prostate cancer, metastatic to the bone, in the Netherlands. Eur Urol 2003, 43(3):226-232.
35. Delea T., Langer C., McKiernan J., Liss M., Edelsberg J., Brandman J., et al. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology 2004, 67(5-6):390-396.
36. Delea T.E., McKiernan J., Brandman J., Edelsberg J., Sung J., Raut M., et al. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. J Thorac Oncol 2006, 1(6):571-576.
37. Delea T., McKiernan J., Brandman J., Edelsberg J., Sung J., Raut M., et al. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol 2006, 4(7):341-347.
38. Kinnane N. Burden of bone disease. Eur J Oncol Nurs 2007, 11(Suppl 2):S28-S31.
39. Major P. Optimal management of metastatic bone disease. Eur J Oncol Nurs 2007, 11(Suppl 2):S32-S37.
40. Schulman K.L., Kohles J. Economic burden of metastatic bone disease in the US. Cancer 2007, 109(11):2334-2342.
41. Felix J., Andreozzi V., Soares M., Gervasio H., Moreira A., Costa L., et al. Direct hospital costs of skeletal-related events in Portuguese patients with breast cancer and bone metastases. J Clin Oncol 2007, 25(18S):17084.
42. Lage M.J., Barber B.L., Harrison D.J., Jun S. The cost of treating skeletal-related events in patients with prostate cancer. Am J Manag Care 2008, 14(5):317-322.